EP 4164607 A1 20230419 - METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH FENOTEROL HYDROBROMIDE, A ß2- ADRENERGIC RECEPTOR AGONIST, AND DERIVATIVES THEREOF
Title (en)
METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING MYOPIA WITH FENOTEROL HYDROBROMIDE, A ß2- ADRENERGIC RECEPTOR AGONIST, AND DERIVATIVES THEREOF
Title (de)
VERFAHREN UND ZUSAMMENSETZUNGEN ZUR PRÄVENTION UND BEHANDLUNG VON MYOPIE MIT FENOTEROLHYDROBROMID, EINEM SS2-ADRENERGEN REZEPTORAGONISTEN UND DERIVATEN DAVON
Title (fr)
MÉTHODES ET COMPOSITIONS POUR PRÉVENIR ET TRAITER LA MYOPIE À L'AIDE DE BROMHYDRATE DE FÉNOTÉROL, UN AGONISTE DU RÉCEPTEUR ß2-ADRÉNERGIQUE, ET DE SES DÉRIVÉS
Publication
Application
Priority
- US 202063037891 P 20200611
- US 2021036614 W 20210609
Abstract (en)
[origin: WO2021252626A1] The disclosure relates to methods and compositions for preventing and/or treating an ocular disease. In particular, the disclosure relates to preventing and/or treating myopia with systemic or topical administration of fenoterol hydrobromide, which is a β2-adrenergic receptor agonist, or a derivative thereof.
IPC 8 full level
A61K 9/00 (2006.01); A61K 31/137 (2006.01); A61P 27/10 (2006.01)
CPC (source: EP IL KR)
A61K 9/0014 (2013.01 - IL); A61K 9/0019 (2013.01 - IL); A61K 9/0048 (2013.01 - IL KR); A61K 9/0053 (2013.01 - IL); A61K 31/137 (2013.01 - EP IL KR); A61K 45/06 (2013.01 - EP IL); A61P 27/10 (2018.01 - EP IL KR); A61K 9/0014 (2013.01 - EP); A61K 9/0019 (2013.01 - EP); A61K 9/0048 (2013.01 - EP); A61K 9/0053 (2013.01 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
WO 2021252626 A1 20211216; CA 3182397 A1 20211216; CN 116194094 A 20230530; EP 4164607 A1 20230419; EP 4164607 A4 20240710; IL 298974 A 20230201; JP 2023530679 A 20230719; KR 20230051152 A 20230417
DOCDB simple family (application)
US 2021036614 W 20210609; CA 3182397 A 20210609; CN 202180061075 A 20210609; EP 21822599 A 20210609; IL 29897422 A 20221211; JP 2022576461 A 20210609; KR 20237001143 A 20210609